Results

Total Results: 2,582 records

Showing results for "testing".

161. Automated-Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/patient-generated-health-data-protocol-chronic-conditions.pdf
     March 17, 2020 - Manufacturers of FDA regulated devices typically are required to demonstrate, through testing, that … If there are no such technologies, then we will expand this testing to include any technologies that … Data Synthesis Direct (hands on) usability and performance testing will be restricted to those … If there are no such technologies, then we will expand this testing to include any technologies … The team realized that the original proposed approach to direct usability and performance testing

162. Automated-Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/health-data-mapping/protocol
     March 01, 2021 - Direct (hands on) usability and performance testing will be restricted to those technologies that are … If there are no such technologies, then we will expand this testing to include any technologies that … Data Synthesis Direct (hands on) usability and performance testing will be restricted to those … If there are no such technologies, then we will expand this testing to include any technologies that … The team realized that the original proposed approach to direct usability and performance testing was

163. Testing Cancer Quality Measures for End-of-Life Care | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/cancer-end-of-life-quality-meaures/research
     January 01, 2020 - Español EHC FAQs Home Evidence Reports Testing … Care SHARE: Testing … Project Timeline Testing Cancer Quality Measures for End of Life Care Jan 1, 2005 … created November 2017 Internet Citation: Research Report: Testing

164. Development and Usability Testing of EPC Evidence Review Dissemination Summaries for Health Systems Decisionmakers (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-usability-testing.pdf
     November 01, 2018 - Development and Usability Testing of EPC Evidence Review Dissemination Summaries for Health Systems Decisionmakers … Methods Research Report Development and Usability Testing of EPC Evidence … Summaries for Health Systems Decisionmakers Methods Research Report Development and Usability Testing … Development and Usability Testing of EPC Evidence Review Dissemination Summaries for Health Systems … We modified the interview guide and format of the interview substantially following pilot testing, in

165. PowerPoint Presentation (ppt file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/medical-test-reviews-applicability.ppt
     June 01, 2012 - Preventive lipid testing in individuals with cardiovascular disease has changed the proportion able to … to treatment, and variable ordering of testing across subjects. … Resources for conventional Pap smear testing were strained at the time, which contributed to the rise … The underlying incidence and prevalence data included: Provided context Informed modeling of testing … impact Reviewers could not estimate the usefulness of human papilloma virus testing among older women

166. PowerPoint Presentation (ppt file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/medical-test-reviews-applicability.ppt
     June 01, 2012 - Preventive lipid testing in individuals with cardiovascular disease has changed the proportion able to … to treatment, and variable ordering of testing across subjects. … Resources for conventional Pap smear testing were strained at the time, which contributed to the rise … The underlying incidence and prevalence data included: Provided context Informed modeling of testing … impact Reviewers could not estimate the usefulness of human papilloma virus testing among older women

167. Disposition of Comments Report for Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/chronic-kidney-disease-anemia-2011_disposition-comments.pdf
     January 01, 2011 - However, considerable heterogeneity is likely to exist between testing platforms/methods, especially … We agree that considerable heterogeneity likely exists between testing platforms, and thus have added … The bundling of dialysis reimbursement has caused most providers to curtail lab testing, which may … Testing needs are different when clinical question is too much versus too little iron. … Testing needs are different when clinical question is too much vs. too little iron.

168. Executive Summary_Comparative Effectiveness Review No. 269: Respectful Maternity Care (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-269-respectful-maternity-care-summary.pdf
     January 01, 2024 - • RMC tools have not been subject to widespread testing and no single validated tool stands out … • Alongside the urgent need to implement RMC, goals for RMC must include further testing of reliable … concept of respectful maternity care is still being defined, a critical step towards wider outcomes testing … Before widespread implementation of tools to measure RMC, further testing of current measures and a

169. Disposition of Comments for PCA3 Testing for the Diagnosis and Management of Prostate Cancer (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_disposition-comments.pdf
     April 01, 2013 - Disposition of Comments for PCA3 Testing for the Diagnosis and Management of Prostate Cancer Comparative … Effectiveness Research Review Disposition of Comments Report Research Review Title: PCA3 Testing … PCA3 Testing for the Diagnosis and Management of Prostate Cancer. … None of the included studies had men enrolled due to results of PCA3 testing. … TEP # 11 General I read the report "PCA3 testing for ... " with interest.

170. Version 2_Risk of Reinfection From SARS-CoV-2 -- An Update of an Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Living Rapid Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/version-2-risk-of-reinfection-from-SARSCoV2_0.pdf
     December 31, 2022 - antibody levels, SARS-CoV-2 variants, or case identification method (e.g., surveillance, symptomatic testing … Antibody testing has been proposed as a potential marker or correlate of protection against infection … In these situations, the prognostic value of antibody testing was identical to the prognostic value … settings when the timing of testing in relation to infection is unknown. … Re- infection with SARS-CoV-2 in Patients Undergoing Serial Laboratory Testing.

171. Pulmonary Arterial Hypertension: Screening, Management, and Treatment | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/hypertension-pulmonary-arterial/research
     December 01, 2019 - to evaluate the comparative validity, reliability, and feasibility of echocardiography and biomarker testing … accuracy and discrimination; however, one good-quality prospective cohort study suggested that biomarker testing … combination of echocardiography and the biomarker NT-proBNP is sufficiently accurate to rule out PAH when testing

172. celiac-disease-protocol-140612 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/celiac-disease_research-protocol.pdf
     June 12, 2014 - The validity and acceptability of the various diagnostic testing regimens and criteria have remained … Finally, in response to a comment about how previously negative testing affects test accuracy, we added … c- length of time ingesting gluten before diagnostic testing? … , including race, genetics, geography, SES e- Patients with IgA deficiency f- Patients previously testing … Positive and negative likelihood ratios • For KQ 1b, for Clinical decision-making o Additional testing

173. Kidney Tests | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/kidney-tests
     January 07, 2016 - Testing is the only way to know how your kidneys are doing.

174. Bowel Movement | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/bowel-movement
     May 30, 2017 - difficile Infection Update Systematic Review Archived February 29, 2012 Fecal DNA Testing … Research Protocol Archived May 18, 2011 Comparative Effectiveness of Fecal DNA Testing

175. Diagnosis and Treatment of Clinical Alzheimer's-type Dementia (CATD) (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/catd-protocol-draft_0.pdf
     November 02, 2018 - Neuropsychological testing may quantify the severity of cognitive impairment and the pattern of cognitive … However, access to comprehensive neuropsychological testing is limited in many clinical settings. … Currently there are no evidence-based guidelines about the merits of either brief cognitive testing … or comprehensive neuropsychological testing in this patient population. … Additional diagnostic testing outcomes will be considered for SOE grading when available data allow.

176. Diagnosis and Treatment of Clinical Alzheimer's-type Dementia (CATD) | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/alzheimers-type-dementia/protocol
     August 01, 2020 - Neuropsychological testing may quantify the severity of cognitive impairment and the pattern of cognitive … However, access to comprehensive neuropsychological testing is limited in many clinical settings. … Currently there are no evidence-based guidelines about the merits of either brief cognitive testing or … comprehensive neuropsychological testing in this patient population. … Additional diagnostic testing outcomes will be considered for SOE grading when available data allow.

177. Can screening among the general adult male population for elevated PCA3 (also known as DD3) gene expression, to identify those at risk for prostate cancer who may be candidates for prostate biopsy, reduce morbidity and mortality? | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/can-screening-among-the-general-adult-male-population-for-elevated-pca3-also-known-as-dd3-gene-expression-to-identify-those-at-risk-for-prostate-cancer-who-may-be-candidates-for-prostate-biopsy-reduce-morbidity-and-mortality
     November 01, 2017 - commercially available PCA3 expression assays for prostate cancer screening tests vs. screening by PSA testing … related outcomes resulting from improved/earlier detection of prostate cancer that may result from testing … Download Topic Suggestion Disposition (PDF, 160 KB) Project Timeline PCA3 Testing

178. Version-3-Immunity-After-Covid-19-Appendix-Table-B-1 (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
     January 24, 2022 - , N (%) Comorbidities, N (%) Assay Type Assay Brand Definition of a positive test Frequency of Ab testing … over the course of the study 05/2020 - 01/2021 Unvacinated, recovered individuals who had a history of testing … stratified, N (%) Male Sex/Gender, N (%) Comorbidities, N (%) Assay Type Assay Brand Frequency of Ab testing … Qatar with RT-PCR test results Centralized and standardized national anti-SARS-CoV-2 serological testing … every 2 weeks; Antibody testing every 4 weeks; Questionnaires re symptoms and exposures every 2 weeks

179. Methods Guide for Medical Test Reviews (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-bias_methods.pdf
     July 01, 2012 - don’t know status” are excluded and do not have their disease status verified (no reference standard testing … Relatives who are DECEASED are excluded from having any verification undertaken (no reference standard testing … Relatives who are UNABLE TO PARTICIPATE in interviews or further clinical testing are excluded from … having any verification method (no reference standard testing).

180. C- Evidence-based Practice Center Technical Brief Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/musculoskeletal-disorders-imaging_research-protocol.pdf
     August 05, 2010 - What are the postulated advantages and disadvantages of positional MRI testing compared to contemporary … Guiding question 2: What is the current availability and cost of positional MRI testing and what are … Approximately how many facilities and of what kind are currently providing positional MRI testing in … etiology (i.e. undiagnosed by conventional diagnostic imaging) Interventions • Positional MRI testing … Moreover, we will record the outcomes being assessed in each study, including testing related harms,